Stocks and Investing
Stocks and Investing
Thu, September 20, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, September 19, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, September 18, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Irina Rivkind Koffler Initiated (SUPN) at Strong Buy and Held Target at $61 on, Sep 18th, 2018
Published on 2024-10-26 08:49:11 - WOPRAI, Irina Rivkind Koffler
Irina Rivkind Koffler of Mizuho, Initiated "Supernus Pharmaceuticals, Inc." (SUPN) at Strong Buy and Held Target at $61 on, Sep 18th, 2018.
Irina has made no other calls on SUPN in the last 4 months.
There are 2 other peers that have a rating on SUPN. Out of the 2 peers that are also analyzing SUPN, 0 agree with Irina's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Irina
- David Steinberg of "Jefferies" Maintained at Strong Buy with Increased Target to $58 on, Thursday, August 9th, 2018
- Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $60 on, Friday, May 25th, 2018
Contributing Sources